News - Headlands Research

About
Our Sites
CROs & Sponsors
Information Hub
- Blog
- Events
- In the Media
- News
- Resources
Careers
Contact

About
Our Sites
CROs & Sponsors
Information Hub
- Blog
- Events
- In the Media
- News
- Resources
Careers
Contact

News

September 2, 2020

Patient happy to get a shot

September 2, 2020

MSN: First American Dosed In Oxford’s Final Trial For Its COVID-19 Vaccine

Read More

September 2, 2020

Coronavirus News Report

September 2, 2020

Today Show: Labor Day Brings New Concerns About Coronavirus Resurgence In The Fall

Read More

September 1, 2020

Patient reading tablet while medical personnel read a different tablet

September 1, 2020

NBC Nightly News: Phase 3 Clinical Trials For Oxford Coronavirus Vaccine Begins

Read More

September 1, 2020

Dr. Larry Bush

September 1, 2020

CBS News (National): AstraZeneca Starts Phase Three Vaccine Trials

Read More

September 1, 2020

Patient giving thumbs up while getting a shot

September 1, 2020

First Patient Dosed in AstraZeneca’s Phase III COVID-19 Vaccine Trial at Headlands’ JEM Research Institute Site in Florida

Read More

August 11, 2020

Woman getting a shot

August 11, 2020

Multiple Headlands Research Sites Selected for AstraZeneca’s Phase III COVID-19 Vaccine Trial

Read More

August 5, 2020

Patient reading information on tablet

August 5, 2020

Wall Street Journal: Covid-19 Vaccine Trials Have a Problem: Minority Groups Don’t Trust Them

Read More

July 16, 2020

Virus image

July 16, 2020

Headlands Research Sites Chosen for Crucial COVID-19 Vaccine Trials

Read More

July 7, 2020

Microscope and test tubes

July 7, 2020

Headlands Research Acquires CNS Global Site Leaders JEM Research Institute and Toronto Memory Program

Read More

June 10, 2020

Human Brain

June 10, 2020

New York Times: When a Drug Study Abruptly Ends, Volunteers Are Left to Cope – Dr. Sharon Cohen

Read More

Posts pagination

← 1 … 3 4 5 →

130 John F Kennedy Dr STE 203 Lake Worth, FL 33462

© 2025 Headlands Research. | Privacy Policy

Facebook
LinkedIn
Twitter